We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Red River Bancshares
RRBI
$672M
| $670K | ﹤0.01% |
10,344
+200
| +2% | +$12.7K |
|
777
PCB Bancorp
PCB
$401M
| $670K | ﹤0.01% |
31,908
+15,467
| +94% | +$333K |
|
778
Denali Therapeutics
DNLI
$3.82B
| $667K | ﹤0.01% |
+45,969
| New | +$661K |
|
779
Great Southern Bancorp
GSBC
$879M
| $665K | ﹤0.01% |
10,857
+276
| +3% | +$16.8K |
|
780
Expedia Group
EXPE
$35.5B
| $664K | ﹤0.01% |
3,108
-381
| -11% | -$76.5K |
|
|
FLNA
781
Filana Therapeutics
FLNA
$42.7M
| $654K | ﹤0.01% |
+224,658
| New | +$517K |
|
782
Gencor Industries
GENC
$221M
| $650K | ﹤0.01% |
+44,397
| New | +$672K |
|
783
HubSpot
HUBS
$12.2B
| $644K | ﹤0.01% |
+1,377
| New | +$693K |
|
784
Fulcrum Therapeutics
FULC
$248M
| $644K | ﹤0.01% |
70,015
-22,455
| -24% | -$162K |
|
785
iRadimed
IRMD
$1.21B
| $644K | ﹤0.01% |
9,046
-198
| -2% | -$13.2K |
|
786
Natural Gas Services Group
NGS
$460M
| $641K | ﹤0.01% |
22,915
| – | – |
|
787
NRG Energy
NRG
$26.9B
| $640K | ﹤0.01% |
3,952
| – | – |
|
788
Amerant Bancorp
AMTB
$1.2B
| $634K | ﹤0.01% |
32,886
-39,804
| -55% | -$803K |
|
789
1st Source
SRCE
$2.18B
| $633K | ﹤0.01% |
10,275
-1,035
| -9% | -$64.9K |
|
790
Mission Produce
AVO
$1.13B
| $629K | ﹤0.01% |
+52,299
| New | +$646K |
|
791
Mativ Holdings
MATV
$482M
| $612K | ﹤0.01% |
54,105
+18,505
| +52% | +$183K |
|
792
Funko
FNKO
$355M
| $610K | ﹤0.01% |
177,197
-702,906
| -80% | -$2.61M |
|
793
Center Bancorp
CNOB
$1.66B
| $604K | ﹤0.01% |
24,326
-2,731
| -10% | -$67.3K |
|
794
Mercantile Bank Corp
MBWM
$1.04B
| $600K | ﹤0.01% |
13,331
-66
| -0.5% | -$3.13K |
|
795
BJ's Restaurants
BJRI
$1.45B
| $599K | ﹤0.01% |
19,610
-12,843
| -40% | -$458K |
|
796
Murphy USA
MUSA
$11.1B
| $598K | ﹤0.01% |
+1,539
| New | +$609K |
|
797
Theravance Biopharma
TBPH
$875M
| $592K | ﹤0.01% |
40,538
+20,364
| +101% | +$257K |
|
798
Apogee Enterprises
APOG
$873M
| $575K | ﹤0.01% |
13,191
-20,440
| -61% | -$877K |
|
799
Maravai LifeSciences
MRVI
$1.01B
| $571K | ﹤0.01% |
198,899
-8,840
| -4% | -$22.6K |
|
800
LoveSac
LOVE
$248M
| $571K | ﹤0.01% |
33,708
-34,676
| -51% | -$645K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.